Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Oral Pharma Edwall AB
AB
Active
Org 5592665367
Hildingavägen 28, 182 62
Djursholm
Business and other management consultancy activities
· NACE 7020
Est. 2020
1 employees
Watchlist
Share
Sweden
/
Companies
/
Business and other management consultancy activities
/
Oral Pharma Edwall AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
1M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
401
643
411
72
31
Staff expenses
—
−103
−170
−19
−0
EBITDA
114
357
−29
3
−14
Depreciation & amort.
−15
−16
−23
−23
−19
EBIT
99
341
−52
−20
−33
Net financials
—
0
−30
1
−1
Profit before tax
72
249
37
−19
−34
Tax
−18
−57
−24
—
—
Net profit
54
192
13
−19
−34
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
201
513
386
312
270
Equity
79
271
285
265
231
Long-term debt
0
—
—
—
—
Short-term debt
95
122
101
47
38
Total debt
95
122
101
47
38
Financial ratios
5-year trend
EBITDA margin
-46.3%
This company
15.8%
Market median
-393% vs market
2021
2025
Equity ratio
85.8%
This company
38.2%
Market median
+125% vs market
2021
2025
Return on equity
-14.6%
This company
18.4%
Market median
-179% vs market
2021
2025
Net profit margin
-110.1%
This company
8.1%
Market median
-1459% vs market
2021
2025
Asset turnover
0.11×
This company
1.12×
Market median
-90% vs market
2021
2025
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-08-01 – 2021-12-31
View
PDF
More on Oral Pharma Edwall AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network